Kenneth N. Olivier
- The tolerability of linezolid in the treatment of nontuberculous mycobacterial diseaseBy Kevin L. Winthrop, Jennifer H. Ku, Theodore K. Marras, David E. Griffith, Charles L. Daley, Kenneth N. Olivier, Timothy R. Aksamit, Katherine Mackey and D. Rebecca PrevotsArticle | Published in 2015 in European Respiratory JournalKevin L. Winthrop1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAJennifer H. Ku1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USATheodore K. Marras2University of Toronto, Toronto, CanadaDavid E. Griffith3University of Texas at Tyler, Tyler, TX, USACharles L. Daley4National Jewish Health, Denver, CO, USAKenneth N. Olivier5National Institute Allergy and Infectious Diseases, Bethesda, MD, USATimothy R. Aksamit6Mayo Clinic, Rochester, MN, USAKatherine Mackey1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAD. Rebecca Prevots5National Institute Allergy and Infectious Diseases, Bethesda, MD, USA
- The tolerability of linezolid in the treatment of nontuberculous mycobacterial diseaseBy Kevin L. Winthrop, Jennifer H. Ku, Theodore K. Marras, David E. Griffith, Charles L. Daley, Kenneth N. Olivier, Timothy R. Aksamit, Cara D. Varley, Katherine Mackey and D. Rebecca PrevotsArticle | Published in 2015 in European Respiratory JournalKevin L. Winthrop1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAJennifer H. Ku1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USATheodore K. Marras2University of Toronto, Toronto, CanadaDavid E. Griffith3University of Texas at Tyler, Tyler, TX, USACharles L. Daley4National Jewish Health, Denver, CO, USAKenneth N. Olivier5National Institute Allergy and Infectious Diseases, Bethesda, MD, USATimothy R. Aksamit6Mayo Clinic, Rochester, MN, USACara D. Varley1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAKatherine Mackey1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAD. Rebecca Prevots5National Institute Allergy and Infectious Diseases, Bethesda, MD, USA
- The tolerability of linezolid in the treatment of nontuberculous mycobacterial diseaseBy Kevin L. Winthrop, Jennifer H. Ku, Theodore K. Marras, David E. Griffith, Charles L. Daley, Kenneth N. Olivier, Timothy R. Aksamit, Cara D. Varley, Katherine Mackey and D. Rebecca PrevotsKevin L. Winthrop1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAJennifer H. Ku1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USATheodore K. Marras2University of Toronto, Toronto, CanadaDavid E. Griffith3University of Texas at Tyler, Tyler, TX, USACharles L. Daley4National Jewish Health, Denver, CO, USAKenneth N. Olivier5National Institute Allergy and Infectious Diseases, Bethesda, MD, USATimothy R. Aksamit6Mayo Clinic, Rochester, MN, USACara D. Varley1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAKatherine Mackey1Divisions of Infectious Diseases, Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USAD. Rebecca Prevots5National Institute Allergy and Infectious Diseases, Bethesda, MD, USA
- Amikacin (AMK) minimum inhibitory concentrations (MICs) and mutational resistance in patients with treatment-refractory nontuberculous mycobacteria (NTM) lung disease (LD) treated with liposomal amikacin for inhalation (LAI)By Kenneth N. Olivier, Gina Eagle, John P. McGinnis II, Liza Micioni, Barbara A. Brown-Elliott and Richard J. Wallace, Jr.Kenneth N. Olivier1Cardiovascular Pulmonary Branch, National Heart, Lung, and Blood Institute / National Institutes of Health, Bethesda, MD United StatesGina Eagle2Clinical, Insmed Incorporated, Bridgewater, NJ United StatesJohn P. McGinnis II2Clinical, Insmed Incorporated, Bridgewater, NJ United StatesLiza Micioni2Clinical, Insmed Incorporated, Bridgewater, NJ United StatesBarbara A. Brown-Elliott3Microbiology, The University of Texas Health Science Center at Tyler, Tyler, TX United StatesRichard J. Wallace, Jr.3Microbiology, The University of Texas Health Science Center at Tyler, Tyler, TX United States
- Development of a quality of life module for nontuberculous mycobacteria (NTM)By Alexandra L. Quittner, Anjana Madan, Estefany Saez-Flores, Kenneth N. Olivier, Kevin Fennelly, Andreas Schmid and Matthias SalatheAlexandra L. Quittner1Department of Psychology, University of Miami, Coral Gables, FL United StatesAnjana Madan1Department of Psychology, University of Miami, Coral Gables, FL United StatesEstefany Saez-Flores1Department of Psychology, University of Miami, Coral Gables, FL United StatesKenneth N. Olivier2Cardiovascular Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD United StatesKevin Fennelly3Division of Infectious Diseases and Global Medicine, University of Florida College of Medicine, Gainesville, FL United StatesAndreas Schmid4Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Miami Miller School of Medicine, Miami, FL United StatesMatthias Salathe4Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Miami Miller School of Medicine, Miami, FL United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.